Bausch Health shares surge 11.02% intraday after Solta Medical acquires Chinese distributor to boost aesthetics market presence.

Bausch Health surged 11.02% intraday after announcing its Solta Medical aesthetics unit acquired Wuhan Shibo Zhenmei Technology, a longtime Chinese distributor. The acquisition consolidates in-house distribution of products like Thermage FLX, enhancing Solta’s ability to meet rising demand in China’s growing aesthetics market. The move strengthens Bausch Health’s market access and operational control in a key growth region, directly aligning with the stock’s sharp intraday rally.